Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?

Mesenchymal stem cells (MSCs) are believed to be promising for cell administration therapy after ischemic stroke. Because of their advantageous characteristics, such as ability of differentiation into neurovascular lineages, avoidance of immunological problems, and abundance of graft cells in mesode...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikegame, Yuka, Yamashita, Kentaro, Nakashima, Shigeru, Nomura, Yuichi, Yonezawa, Shingo, Asano, Yoshitaka, Shinoda, Jun, Hara, Hideaki, Iwama, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204523/
https://www.ncbi.nlm.nih.gov/pubmed/25374506
http://dx.doi.org/10.3389/fncel.2014.00322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204523/
https://www.ncbi.nlm.nih.gov/pubmed/25374506
http://dx.doi.org/10.3389/fncel.2014.00322

Ejemplares similares